Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
ABBOTT LABORATORIES
By:
/s/
THOMAS C. FREYMAN
Thomas C. Freyman
Senior Vice President, Finance
and Chief Financial Officer